Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Jakarta - Delayed Quote IDR

PT Hetzer Medical Indonesia Tbk (MEDS.JK)

Compare
50.00
0.00
(0.00%)
At close: March 27 at 2:01:39 PM GMT+7
Loading Chart for MEDS.JK
  • Previous Close 50.00
  • Open 50.00
  • Bid --
  • Ask 50.00 x --
  • Day's Range 50.00 - 50.00
  • 52 Week Range 50.00 - 50.00
  • Volume 200
  • Avg. Volume 25,372
  • Market Cap (intraday) 78.125B
  • Beta (5Y Monthly) 0.96
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

PT Hetzer Medical Indonesia Tbk manufactures and sells masks with 4D designs in Indonesia. It offers surgical, hijab series, kids, and other masks, as well as antiseptic hand rub products. The company was founded in 2010 and is based in Cimahi, Indonesia.

www.evoplusmed.com

25

Full Time Employees

December 31

Fiscal Year Ends

Recent News: MEDS.JK

View More

Performance Overview: MEDS.JK

Trailing total returns as of 3/27/2025, which may include dividends or other distributions. Benchmark is IDX COMPOSITE (^JKSE) .

YTD Return

MEDS.JK
0.00%
IDX COMPOSITE (^JKSE)
8.04%

1-Year Return

MEDS.JK
0.00%
IDX COMPOSITE (^JKSE)
10.94%

3-Year Return

MEDS.JK
70.24%
IDX COMPOSITE (^JKSE)
7.02%

5-Year Return

MEDS.JK
70.24%
IDX COMPOSITE (^JKSE)
43.23%

Compare To: MEDS.JK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MEDS.JK

View More

Valuation Measures

Annual
As of 3/31/2025
  • Market Cap

    78.12B

  • Enterprise Value

    78.12B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.07%

  • Return on Assets (ttm)

    -1.02%

  • Return on Equity (ttm)

    -3.44%

  • Revenue (ttm)

    17.29B

  • Net Income Avi to Common (ttm)

    -2.09B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    412.76M

  • Total Debt/Equity (mrq)

    9.78%

  • Levered Free Cash Flow (ttm)

    3.5B

Research Analysis: MEDS.JK

View More

Company Insights: MEDS.JK

Research Reports: MEDS.JK

View More

People Also Watch